DURHAM, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Argonaut ...

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of KBI PUREplatform™, a premium microbial cell line development (CLD ...

Durham, N.C., Carlsbad, Calif., United States: KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization ...

Big Pharma veteran Peter Carbone has joined KBI Biopharma as chief quality officer, the contract development and manufacturing organization announced April 1. His role oversees KBI’s quality and ...

Durham, North Carolina (August 10, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments to continue its momentum and vision of becoming a ...

In this article, Michael Landau outlines factors driving biopharma companies to rely on CDMOs and highlights some of the contributions that CDMOs bring to their customers. Never miss a story ...

DURHAM, N.C., July 23, 2024--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced ...

DURHAM, N.C. — KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new ...

GENEVA — KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, announced today that an expanded, fully-integrated mammalian contract development and manufacturing services facility ...